Full List Of Stories
Report criticises lack of detailed data from Moderna's Covid-19 vaccine trial
Shares of Moderna Therapeutics finished sharply lower after "several vaccine experts" cast doubt on the company's claim that its Covid-19 vaccine candidate had generated a significant immune response in a small sample of patients.
Wednesday preview: Fed minutes, Compass Group in the spotlight
The market spotlight will shift back towards the US on Wednesday as investors wait on the release of the minutes of the US Federal Reserve's last policy meeting on 28-29 April.
Europe close: Dax outperforms amid profit-taking, periphery markets weakest
Stocks finished modestly in the red on Tuesday as the latest economic data laid bare the task that lay ahead in order for governments to get their economies back on track.
JP Morgan reiterates BHP and Anglo American as its 'top picks' in European mining
Analysts at JP Morgan reiterated their preference for shares of BHP and Anglo American in the European mining space, citing a host of factors.
US housing starts drop sharply in April, but recovery anticpated
New home construction in the States fell rapidly last month as the Covid-19 pandemic swept across the nation.
Europe midday: Stocks dip amid profit taking, selling stronger in euro area periphery
Stocks remained modestly in the red come midday on Tuesday as the latest economic data laid bare the task that lay ahead for governments to get their economies back on track.
Europe open: Stocks dip as investors mull EU reconstruction fund
Early gains for stocks have given way to modest selling across the Continent as investors monitor the news-flow around a proposed €500bn reconstruction fund for the euro area.